Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories LLC, a subsidiary in Ukraine, has been fined EUR 280 by the State Tax Service of Ukraine for an 8-day delay in receiving goods from non-resident entities. The company assures investors that this penalty will not materially affect its financials or operations. Despite the penalty, Dr. Reddy’s maintains its strong market position and financial stability.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.